• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕激素受体基因变异与子宫内膜癌风险。

Progesterone receptor gene variants and risk of endometrial cancer.

机构信息

Genetics and Population Health Division, Queensland Institute of Medical Research, Herston, Brisbane, Queensland 4006, Australia.

出版信息

Carcinogenesis. 2011 Mar;32(3):331-5. doi: 10.1093/carcin/bgq263. Epub 2010 Dec 10.

DOI:10.1093/carcin/bgq263
PMID:21148628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3105584/
Abstract

Prolonged excessive estrogen exposure unopposed by progesterone is widely accepted to be a risk factor for endometrial cancer development. The physiological function of progesterone is dependent upon the presence of its receptor [progesterone receptor (PGR)] and several studies have reported single nucleotide polymorphisms (SNPs) in the PGR gene to be associated with endometrial cancer risk. We sought to confirm the associations with endometrial cancer risk previously reported for four different PGR polymorphisms. A maximum of 2888 endometrial cancer cases and 4483 female control subjects from up to three studies were genotyped for four PGR polymorphisms (rs1042838, rs10895068, rs11224561 and rs471767). Logistic regression with adjustment for age, study, ethnicity and body mass index was performed to calculate odds ratios (ORs) and associated 95% confidence intervals (CIs) and P-values. Of the four SNPs investigated, only rs11224561 in the 3' region of the PGR gene was found to be significantly associated with endometrial cancer risk. The A allele of the rs11224561 SNP was associated with increased risk of endometrial cancer (OR per allele 1.31; 95% CI 1.12-1.53, P = 0.001, adjusted for age and study), an effect of the same magnitude and direction as reported previously. We have validated the endometrial cancer risk association with a tagSNP in the 3' untranslated region of PGR previously reported in an Asian population. Replication studies will be required to refine the risk estimate and to establish if this, or a correlated SNP, is the underlying causative variant.

摘要

长期、过度的雌激素暴露而无孕激素拮抗被广泛认为是子宫内膜癌发展的一个危险因素。孕激素的生理功能依赖于其受体[孕激素受体(PGR)]的存在,几项研究报道 PGR 基因中的单核苷酸多态性(SNP)与子宫内膜癌风险相关。我们试图证实先前报道的与子宫内膜癌风险相关的四种不同 PGR 多态性。最多有来自三个研究的 2888 例子宫内膜癌病例和 4483 例女性对照进行了四个 PGR 多态性(rs1042838、rs10895068、rs11224561 和 rs471767)的基因分型。采用调整年龄、研究、种族和体重指数的 logistic 回归计算比值比(OR)及其相关的 95%置信区间(CI)和 P 值。在所研究的四个 SNP 中,只有 PGR 基因 3'区域的 rs11224561 与子宫内膜癌风险显著相关。rs11224561 SNP 的 A 等位基因与子宫内膜癌风险增加相关(每个等位基因的 OR 为 1.31;95%CI 为 1.12-1.53,P = 0.001,调整年龄和研究),其作用的大小和方向与先前报道的一致。我们已经验证了先前在亚洲人群中报道的 PGR 3'非翻译区标记 SNP 与子宫内膜癌风险的关联。需要进行复制研究来细化风险估计,并确定这是或相关 SNP 是潜在的致病变异。

相似文献

1
Progesterone receptor gene variants and risk of endometrial cancer.孕激素受体基因变异与子宫内膜癌风险。
Carcinogenesis. 2011 Mar;32(3):331-5. doi: 10.1093/carcin/bgq263. Epub 2010 Dec 10.
2
Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population.中国人群中孕激素受体基因与子宫内膜癌风险的关联
Cancer. 2009 Jun 15;115(12):2693-700. doi: 10.1002/cncr.24289.
3
Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.孕激素受体基因遗传变异与子宫内膜癌风险:基于单体型的研究方法。
Carcinogenesis. 2010 Aug;31(8):1392-9. doi: 10.1093/carcin/bgq113. Epub 2010 Jun 13.
4
Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.孕激素受体(PGR)基因变异与乳腺癌及其相关特征的关系:一项病例对照研究。
Pathol Oncol Res. 2020 Jan;26(1):141-147. doi: 10.1007/s12253-017-0379-z. Epub 2018 Jan 4.
5
Genetic variation in the progesterone receptor gene and susceptibility to recurrent pregnancy loss: a case-control study.孕激素受体基因遗传变异与复发性妊娠丢失易感性的关系:一项病例对照研究。
BJOG. 2018 May;125(6):729-735. doi: 10.1111/1471-0528.14949. Epub 2017 Nov 13.
6
Contribution of PGR genetic polymorphisms to the pathogenesis of endometrial cancer: A meta-analysis.孕激素受体(PGR)基因多态性对子宫内膜癌发病机制的贡献:一项荟萃分析。
J Cancer Res Ther. 2015 Oct-Dec;11(4):810-7. doi: 10.4103/0973-1482.146124.
7
Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.孕激素受体基因与乳腺癌风险的关联:一种单核苷酸多态性标签法。
Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):675-82. doi: 10.1158/1055-9965.EPI-05-0679.
8
Genetic variation in progesterone receptor gene and ovarian cancer risk: A case control study.孕激素受体基因遗传变异与卵巢癌风险:病例对照研究。
Gene. 2022 Apr 30;820:146288. doi: 10.1016/j.gene.2022.146288. Epub 2022 Feb 7.
9
CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk.CHEK2、MGMT、SULT1E1和SULT1A1基因多态性与子宫内膜癌风险
Twin Res Hum Genet. 2011 Aug;14(4):328-32. doi: 10.1375/twin.14.4.328.
10
Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.孕激素受体基因多态性与乳腺癌风险:两项澳大利亚乳腺癌研究的结果
Breast Cancer Res Treat. 2008 May;109(1):91-9. doi: 10.1007/s10549-007-9627-3. Epub 2007 Jun 26.

引用本文的文献

1
Meta-Analysis of 49 SNPs Covering 25,446 Cases and 41,106 Controls Identifies Polymorphisms in Hormone Regulation and DNA Repair Genes Associated with Increased Endometrial Cancer Risk.Meta 分析 49 个 SNP(单核苷酸多态性),涵盖 25446 例病例和 41106 例对照,鉴定出与子宫内膜癌风险增加相关的激素调节和 DNA 修复基因中的多态性。
Genes (Basel). 2023 Mar 17;14(3):741. doi: 10.3390/genes14030741.
2
Association of the PROGINS PgR polymorphism with susceptibility to female reproductive cancer: A meta-analysis of 30 studies.PROGINS PgR 多态性与女性生殖系统癌症易感性的关联:30 项研究的荟萃分析。
PLoS One. 2022 Jul 15;17(7):e0271265. doi: 10.1371/journal.pone.0271265. eCollection 2022.
3
Single nucleotide polymorphism of SREBF-1 gene associated with an increased risk of endometrial cancer in Chinese women.SREBF-1基因单核苷酸多态性与中国女性子宫内膜癌风险增加相关。
PLoS One. 2014 Mar 10;9(3):e90491. doi: 10.1371/journal.pone.0090491. eCollection 2014.
4
Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women.孕激素受体基因(PGR)变异与非裔美国妇女乳腺癌风险的关联。
Breast Cancer Res Treat. 2013 Jun;139(3):833-43. doi: 10.1007/s10549-013-2592-0. Epub 2013 Jun 14.
5
Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis.+331G/A PgR 多态性与女性生殖系统癌症易感性的关联:荟萃分析证据。
PLoS One. 2013;8(1):e53308. doi: 10.1371/journal.pone.0053308. Epub 2013 Jan 22.
6
Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.性激素相关基因、循环性激素的选择多态性与子宫内膜癌风险。
Cancer Epidemiol. 2012 Oct;36(5):445-52. doi: 10.1016/j.canep.2012.04.006. Epub 2012 May 25.
7
Genome-wide association study identifies a possible susceptibility locus for endometrial cancer.全基因组关联研究发现子宫内膜癌的一个可能易感位点。
Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):980-7. doi: 10.1158/1055-9965.EPI-11-1160. Epub 2012 Mar 16.
8
DNA repair gene variants in endometrial carcinoma.子宫内膜癌中的 DNA 修复基因变异。
Med Oncol. 2012 Dec;29(4):2949-54. doi: 10.1007/s12032-012-0162-7. Epub 2012 Jan 22.
9
Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study.乳腺癌易感性多态性与子宫内膜癌风险:协作性子宫内膜癌研究。
Carcinogenesis. 2011 Dec;32(12):1862-6. doi: 10.1093/carcin/bgr214. Epub 2011 Sep 30.
10
Rare variants in the ATM gene and risk of breast cancer.ATM 基因中的罕见变异与乳腺癌风险。
Breast Cancer Res. 2011 Jul 25;13(4):R73. doi: 10.1186/bcr2919.

本文引用的文献

1
Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.孕激素受体基因遗传变异与子宫内膜癌风险:基于单体型的研究方法。
Carcinogenesis. 2010 Aug;31(8):1392-9. doi: 10.1093/carcin/bgq113. Epub 2010 Jun 13.
2
Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population.中国人群中孕激素受体基因与子宫内膜癌风险的关联
Cancer. 2009 Jun 15;115(12):2693-700. doi: 10.1002/cncr.24289.
3
Re: Excess of early onset multiple myeloma in endometrial cancer probands and their relatives suggests common susceptibility.回复:子宫内膜癌先证者及其亲属中早发型多发性骨髓瘤的高发提示存在共同易感性。
Gynecol Oncol. 2008 Apr;109(1):153; author reply 154. doi: 10.1016/j.ygyno.2007.12.010. Epub 2008 Jan 29.
4
Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.激素代谢与DNA修复基因单核苷酸多态性与上皮性卵巢癌的关联:两项澳大利亚研究及一个额外验证集的结果
Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2557-65. doi: 10.1158/1055-9965.EPI-07-0542.
5
Biological roles of estrogen and progesterone in human endometrial carcinoma--new developments in potential endocrine therapy for endometrial cancer.雌激素和孕激素在人子宫内膜癌中的生物学作用——子宫内膜癌潜在内分泌治疗的新进展
Endocr J. 2007 Dec;54(5):667-79. doi: 10.1507/endocrj.kr-114. Epub 2007 Sep 4.
6
Hormone replacement therapy and cancers: the biological roles of estrogen and progestin in tumorigenesis are different between the endometrium and breast.激素替代疗法与癌症:雌激素和孕激素在子宫内膜和乳腺肿瘤发生中的生物学作用有所不同。
Tohoku J Exp Med. 2007 May;212(1):1-12. doi: 10.1620/tjem.212.1.
7
Progesterone receptor (PROGINS) polymorphism and the risk of endometrial cancer development.孕激素受体(PROGINS)多态性与子宫内膜癌发生风险
Int J Gynecol Cancer. 2007 Jan-Feb;17(1):229-32. doi: 10.1111/j.1525-1438.2006.00767.x.
8
Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.绝经后激素替代疗法与子宫内膜癌的病例对照研究
Am J Epidemiol. 2006 Oct 15;164(8):775-86. doi: 10.1093/aje/kwj316. Epub 2006 Sep 22.
9
No association between progesterone receptor gene +331G/A polymorphism and endometrial cancer.
Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1415-6. doi: 10.1158/1055-9965.EPI-06-0215.
10
Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinoma.孕激素受体基因异常与复发性子宫内膜癌风险
J Pathol. 2005 Apr;205(5):597-605. doi: 10.1002/path.1738.